A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Phase 2 Completed 39 enrolled Aclaris Therapeutics, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluate the safety and efficacy of hydrogen peroxide, A-101 Solution 40% for the treatment of DPN lesions on subjects with a Fitzpatrick Skin Type of 5 or 6.

Timeline

Start: 2017-06-26
Primary completion: 2019-01-08
Completion: 2019-01-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydrogen Peroxide	Small molecule	40 %	Topical

A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Summary

Timeline

Drugs

Indications